Gonzalez, M., Silva, I. P. D., Wilmott, J. S., Menzies, A. M., Gide, T. N., Adegoke, N. A., Sandhu, S., Carlino, M. S., Atkinson, V., Akkooi, A. C. J. V., Spillane, A. J., Ferguson, P. M., Ch'ng, S., Shannon, K. F., Pennington, T. E., Saw, R. P., Rawson, R. V., Hsiao, E., Lo, S. N., Long, G. V. (2026). NeoIRENIE: A phase 2 randomized trial of intensified neoadjuvant therapy for melanoma patients with multi-omic biomarker or clinically predicted poor response to standard immune checkpoint inhibitor (ICI) therapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps9610